The VANHEALTHING Cryptofund of Biotech innovations is an absolutely unique investment platform: profits are combined with premier access to cutting-edge biotechnological projects that save and improve human lives.
ICO starts in
Managing partner and board member of USP Capital Ltd. and VANHEALTHING Cryptofund of biotech innovations.
Managing partner and board member of venture capital fund USP Capital Ltd. And VANHEALTHING Cryptofund of biotech innovations.
Managing partner of VANHEALTHING Cryptofund of biotech innovations. Expert in investment and high-tech ecosystems.
CEO and co-founder of biotech company Planexta Inc. Expert in biotech management.
PhD in biophysics, director of the Institute of High Technologies. Leads projects in bio-photonics, oncology, medical lasers and other fields.
PhD in technical sciences, expert in complex mathematical analysis. Author of advanced computational models in biotech projects (for example – reading a person’s biodata and emotional state through a phone camera).
World-class Big Data and computer engineering researcher. Author of Metarhia – a cutting-edge Big Data analytics engine used by Chinese interactive TV channels.
Founder and managing Partner of Sikorsky Challenge
Victoria Ustimenko - Chief PR Officer at the VanHealthing CryptoFund of Biotech Innovations. Portfolio of Victoria counts a number of successfully implemented pr campaigns of 2017 for such brands as SingularityNET, Blackmoon Crypto, WishFinance, Paragon Coin, Sonm as a part of the agency ICO Promo.
Sergey Stirenko is the head of the R&D department of supercomputer calculations, AI and AR/VR of the VANHEALTHING Cryptofund of biotech innovations. Sergey is a high-level specialist in the field of artificial intelligence, virtual and augmented reality, as well as supercomputer calculations.
Improve your life and shape the future!
We provide amazing biotech products that normally take years to reach the public. Don’t wait to increase your life’s span and quality – get access now!
Medical technologies should be affordable and transparent. We believe in a sustainable business model based on social responsibility and earning our clients’ trust.
Invest efficiently into functioning successful projects and early R&D advancements. We offer complete transparency, great profit projections and effective financial management.
Read about us in full detail! VANHEALTHING opens up an entire world of astounding biotechnological projects. We present a comprehensive description of our successful portfolio companies, world-class scientists, professional managers and investment methods.
First angel investment into the Force project.
The USP Capital venture fund is launched.
First successful Kickstarter campaign completed by our portfolio company.
Successful cardio-screening of 22 433 patients in rural areas. The Platform 20k project is born.
Plans for the world’s first psychometer are formulated – a unique device for constant monitoring of an individual’s psycho-emotional state.
The TRL3 experiment for the world’s first one-hand ECG sensor is successfully conducted.
Incorporation of Platform 20k and Planexta Inc.
Start of development on PRECISE – the automated ECG interpretation project.
Start of development on the world’s first sleeveless arterial blood pressure monitor with +-5 mm Hg accuracy.
Creation of the SenceBand TRL6 prototype.
Successful completion of the SenceBand crowdfunding campaign.
SenceBand receives two CES 2017 awards in the biotechnologies and wearable devices categories.
- One of our portfolio companies is chosen for the Vertical accelerator (Finland), considered to be one of the world’s best accelerators in digital health tech.
The TRL4 prototype is created by Planexta Care. This is the world’s first sleeveless arterial blood pressure monitor with +-3 mm Hg accuracy.
- One of our portfolio companies is chosen for the Alchemist accelerator (U.S.A.), considered to be one of the world’s best accelerator programs.
- The digital beta of PRECISE is launched.
Start of clinical trials for PRECISE.
The Fund’s portfolio increases to 12 companies – a major new milestone.
Start of the Fund’s transformation into a cryptocurrency fund.
- Creation of the TRL4 prototype of Pure Purr – a VR-based technology for human nervous system analysis.
- Establishment of SenceTech – the company responsible for implementing Planexta Inc. technologies in the United States and other developed countries.
- The Cryptofund’s development strategy is finalized.
- Publication of a fundamental scientific paper on aging predictor analysis and the dynamic estimation of biological age.
- Development of a unique new algorithm for ECG annotation.
- Establishment of Precise Cardiology Limited, which provides automated ECG interpretation services to healthcare systems.
- The Cryptofund’s portfolio is created.
- The medical version of SenceBand is named among the top 20 remote assistance projects of 2017 by HealthcareTech Outlook.
- Pre-clinical trials of Pure Purr begin.
- SenceTech is chosen as one of the three biotech companies at TechCrunch Disrupt (Berlin).
- SenceTech is selected for the Web Summit PITCH.
The Fund conducts a Roadshow for the purpose of engaging investors and partners for the Cryptofund.
Establishment and registration of the Cryptofund.
Creation of the Cryptofund’s board of directors and investment strategy.
Preparation for the ITO and coordination with regulators for the purpose of issuing tokens.
Establishment of the Cryptofund’s hedge-fund division for the purpose of liquidity management.
Demonstration of successful technological and financial results by the Cryptofund’s portfolio companies.
Launch of our ITO
- Portfolio companies begin investment using gathered funds.
- Launch of the first stage of our A.R.K. infrastructure project, specifically – the initial laboratory construction phase.
payment of dividends to token owners.
Launch of the final stage of the A.R.K. infrastructure project.
Launch of new technological projects within the Cryptofund.
Chief Promotion Officer of VANHEALTHING fund, founder and CEO of media holding ESM.one, which unites three innovative IT platforms (ESC, Fundy.us and Zeer.tv) in the fields of Big Data analytics, online payments and promotion of e-sports on the global scene. Has experience in managing large teams, as well as promoting media and high-tech projects.
Dr. Greg Colvin
Greg is a Core Developer of the Ethereum Virtual Machine. His career spans decades, from a psychology PhD at Cornell through artificial intelligence, optical storage, and information retrieval startups in Boulder and San Francisco, optimization of the JVM interpreter in the Oracle kernel, and service on the C++ standards committee, to his current incarnation as the Gandalf of Ethereum. He likes fast cars and loud guitars.
Dr. Ben Goertzel
Dr. Ben Goertzel, best known as the father of Artificial General Intelligence, has also been at the forefront of the application of AI to biomedicine and specifically the genomics of longevity, for nearly two decades. He has worked directly with the National Institutes of Health (NIH), one of the world's foremost medical research centers and US Centers for Disease Control and Prevention (CDC) in applying AI towards discovering critical aspects of the genetic basis for Parkinson’s Disease, Chronic Fatigue Syndrome and Alzheimer’s. Dr. Goertzel has published 141 scientific articles and 12 scientific books in the field of AI.
Experienced strategy professional with 4+ years with McKinsey & Company. MBA at Harvard Business School. Executive member of 60’000+ ETH ICO team with focus on building partnerships and strategy. Co-Founder of Imbiber. Previously Business Development at leading Russian eGrocery startup.
Los Angeles, USA
One one of the world's most influential transhumanists. The author of The Transhumanist Wager, a philosophical science fiction novel. Zoltan Istvan is a world leader in science, technology, and futurist issues. In late 2014, Istvan announced his intent to run for President of the United States in the 2016 elections to raise awareness for transhumanist politics issues. In 2017, Istvan announced his intent to run for Governor of California in the 2018 election as a member of the Libertarian Party.
Ira S. Pastor
Chief Executive Officer – Bioquark Inc. - a novel life sciences company focused on inducible, endogenous regeneration and cellular repair, to bring an end to many of the most devastating ailments associated with human disease, degeneration, and death - 30 years of experience across multiple sectors of the pharmaceutical industry including pharmaceutical commercialization, biotech drug development, managed care, distribution, OTC, and retail. He is also a Board Member of RegenerAge SAPI de CV - a clinical company focused on expedited translational therapeutic applications of regenerative and rejuvenative healthcare interventions, the Reanima Project, member of the Executive Council of the World Academy of Medical Science – WAMS, and member of the World Economic Forum's Human Enhancement council.
San Francisco, USA
Analyst, journalist, digital nomad. Venture Beat contributor, succesfull marketer, visioner. Has been involved in sales, marketing and running software companies since computers had black screens with the ‘wide choice’ of green or orange text.
Vanhealthing network token
Register to have an opportunity to buy token.